<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Endogenous plasma levels of granulocyte colony stimulating factor (G- CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF),IL-6 and IL-10 were measured in a total of 70 patients undergoing cytoreductive chemotherapy for treatment of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> or non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo>. the diagnoses were <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>; n = 30), <z:hpo ids='HP_0011009'>acute</z:hpo> lymphoblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (ALL;n=6), non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (NHL; n=11) and other malignant <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">haematological disorders</z:e> including <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (n=23) </plain></SENT>
<SENT sid="1" pm="."><plain>After chemotherapy, plasma G-CSF was elevated (mean 5.6 ng/ml; range 1.2-10 ng/ml), and was inversely correlated with white blood cell counts (WBC) (r=-0.7, p&lt;0.001) </plain></SENT>
<SENT sid="2" pm="."><plain>Occurrence of <z:hpo ids='HP_0001945'>fever</z:hpo> (T&gt;38.0 degrees C) during severe <z:e sem="disease" ids="C0854467" disease_type="Disease or Syndrome" abbrv="">myelosuppression</z:e> (WBC&lt;1x10(9)/1) was associated with an additional increase of G-CSF levels (P&lt;0 </plain></SENT>
<SENT sid="3" pm="."><plain>(P&lt;0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>Plasma IL-6 correlated significantly with <z:hpo ids='HP_0001945'>fever</z:hpo> (range &lt;1 to 1100 pg/ml, mean 130 pg/ml; r=0.5, P&lt;0.001) but revealed only a weak association with WBC or platelet counts </plain></SENT>
<SENT sid="5" pm="."><plain>In patients treated with recombinant G-CSF (n = 9), an association between IL-6 and <z:hpo ids='HP_0001945'>fever</z:hpo> was still observed after chemotherapy </plain></SENT>
<SENT sid="6" pm="."><plain>During the nonfebrile status (total n = 242; <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> n = 124), IL-6 levels remained &lt;9 pg/ml in 90% of cases, whereas G-CSF increased with <z:e sem="disease" ids="C0023530" disease_type="Disease or Syndrome" abbrv="">leucopenia</z:e> (r = -0.72;P&lt;0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, endogenous GM-CSF remained <z:mpath ids='MPATH_458'>normal</z:mpath> and IL-10 showed only a slight increase (21% of samples; maximum 22 pg/ml) in severe <z:e sem="disease" ids="C0023530" disease_type="Disease or Syndrome" abbrv="">leucopenia</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>In particular, IL-10 levels did not correlate with G-CSF or IL-6 levels </plain></SENT>
<SENT sid="9" pm="."><plain>We conclude that systemic release of G-CSF and IL-6 is obviously nit abrogated by cytoreductive chemotherapy in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> and NHL may add to the therapeutic efficacy of recombinant cytokines </plain></SENT>
<SENT sid="10" pm="."><plain>Also, plasma levels of G-, GM-CSF or IL-6 appear to be regulated by separate mechanisms </plain></SENT>
</text></document>